DCOY

Decoy Therapeutics Inc Cross-source read$2.67 2.20%
Health CareCUSIP 79400X602· EOD Sep 11, 2026

Among active 13F managers last quarter, 3 opened and none reduced or exited; the largest holder to move was Tower Research Capital LLC (TRC) (new position). No open-market insider trades in the last 180 days.

Tracked 13F holders
6
13F value (tracked)
$40K
Smart-money readBullish
Net sellingNet buying
Funds · active managers, latest 13F
3 adding · 0 trimming
Insiders · Form 4 open-market, 180d
0 buying · 0 selling
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean in and no leg opposes.

Price & smart-money activity

$2.67 2.20%5Y -100.0%
$2.46$10,791$21,580$32,368$43,157202120222023202420252026210222
Hover for who · click for detailEnd-of-day closing prices52w $2.63 – $68.28

Who owns DCOY?

6 tracked 13F filers · ranked by shares held

6 tracked 13F filers disclose a position in DCOY as of the latest SEC 13F filings, a combined $40K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Vanguard Capital Management LLC4K
$29K
New
+4K sh
Q2 2026
2Tower Research Capital LLC (TRC)1K
$7K
New
+1K sh
Q1 2026
3UBS Group AG546
$4K
New
+546 sh
Q1 2026
4Advisory Services Network, LLC41
$268
New
+41 sh
Q1 2026
5Caitong International Asset Management Co., Ltd2
$14
New
+2 sh
Q2 2026
6Morgan Stanley1
$7
New
+1 sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is DCOY being bought or sold by institutions?

Last quarter, 3 funds opened a new position in DCOY, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
3
funds took a first position
Biggest moves · ranked by size of the change, positions above a floor

Funds that own DCOY also own

CompanyCo-held byTheir position there
Apple IncAAPL3 funds$360.8M
Nvidia CorpNVDA3 funds$282.5M
Walmart IncWMT3 funds$182.8M
Amazon.com IncAMZN3 funds$145.9M
Alphabet Inc-CL AGOOGL3 funds$137.1M
Micron Technology IncMU3 funds$115.2M
Tesla IncTSLA3 funds$112.1M
JPMorgan Chase & CoJPM3 funds$82.7M
Alphabet Inc-CL CGOOG3 funds$75.3M
Eli Lilly & CoLLY3 funds$73.1M
Advanced Micro DevicesAMD3 funds$69.6M
Chevron CorpCVX3 funds$61.9M

Ranked by how many of DCOY's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in DCOY.

Insider activity (Form 4)

Full insider page →
Net · 180d
$0
0 open-market transactions
DateInsiderRoleActionSharesValue
Dec 30, 2025Hanish Arnold CDirectorSell (S)
2 lots, same day
27$17
Nov 20, 2025Rosenblum Mark JExec VP Finance, CFOBuy (P)20K$16K
Nov 20, 2025Hanish Arnold CDirectorBuy (P)5K$4K
Jun 7, 2022Burleson TessDirectorBuy (P)28K$5K
Jun 7, 2022Lieber Jonathan IDirectorBuy (P)38K$7K
Jun 6, 2022McVicar William K.DirectorBuy (P)27K$5K
Jun 3, 2022Hanish Arnold CDirectorBuy (P)28K$5K
May 31, 2022Rosenblum Mark JExec VP Finance, CFOBuy (P)28K$5K
May 26, 2022Arthur David J.Chief Executive Officer, DirectorBuy (P)
5 lots, same day
44K$8K
Mar 3, 2022Arthur David J.Chief Executive Officer, DirectorBuy (P)139K$54K
Mar 3, 2022Rosenblum Mark JExec VP Finance, CFOBuy (P)76K$30K
Aug 17, 2021Arthur David J.Chief Executive Officer, DirectorBuy (P)
2 lots, same day
4K$4K

One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
00
Insiders
Form 4 open-market
00$0
US House
STOCK Act trades
00$0
Sector rotation
DCOY is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Recent filings

10 most recent

Keep exploring

Connected entities for DCOY

Browse more

Build

Ask your agent what changed in DCOY

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/DCOY/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for DCOY.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for DCOY. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.